MetLife Investment Advisors »

Iovance Biotherapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 146k 9.39
2024-06-30 $1.2M 146k 8.02
2023-12-31 $985k 121k 8.13
2023-09-30 $551k 121k 4.55
2023-06-30 $772k 110k 7.04
2023-03-31 $480k 79k 6.11
2022-12-31 $502k 79k 6.39
2022-09-30 $753k 79k 9.58
2022-06-30 $867k 79k 11.04
2022-03-31 $83k 5.0k 16.65
2021-09-30 $50k 2.0k 24.53
2020-03-31 $1.5M 49k 29.94
2019-12-31 $1.4M 52k 27.68
2019-09-30 $939k 52k 18.20
2019-06-30 $1.2M 48k 24.52
2019-03-31 $459k 48k 9.50
2018-12-31 $428k 48k 8.85
2018-09-30 $677k 60k 11.25